Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NADPH Oxidase Organizer 1 (NOXO1) is a cytosolic protein that functions as an organizer subunit for NOX1 and NOX3 NADPH oxidases. It is essential for their assembly and activation, resulting in the production of reactive oxygen species (ROS), such as superoxide. NOXO1 contains a PX domain for phospholipid binding and two SH3 domains for protein-protein interactions. It plays a role in otoconia biogenesis and modulates Notch signaling via ADAM17 regulation, impacting endothelial cell behavior and angiogenesis. Dysregulation of NOXO1 is implicated in oxidative stress-related diseases, diabetes-related kidney damage, and vascular dysfunction.
Modulates NADPH oxidase activity by organizing and activating NOX1 and NOX3 enzymes, leading to altered ROS production and downstream signaling.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NADPH Oxidase Organizer 1 (NOXO1).